FDA approves second monoclonal antibody treatment for early Alzheimer’s disease
By
Kristen Fischer
Jul 02, 2024
The US Food and Drug Administration (FDA) approved a second monoclonal antibody treatment for for early Alzheimer’s on Tuesday. Eli Lilly’s Kisunla (donanemab), which has proven to slow the disease...
Clinical briefs for Thursday, May 16
By
Kristen Fischer
May 15, 2024
Study: Sleep apnea severity linked to verbal memory decline … Test ties mobility to cognitive function … Spotting osteosarcopenia in heart valve operation patients could predict post-surgical death...